195 related articles for article (PubMed ID: 6984040)
1. [ANF-negative subacute cutaneous lupus erythematosus with anti-Ro antibodies. A new subset of lupus with characteristic skin manifestations].
Bardach H
Hautarzt; 1982 Oct; 33(10):537-41. PubMed ID: 6984040
[TBL] [Abstract][Full Text] [Related]
2. Serum autoantibodies in systemic lupus erythematosus and correlation with cutaneous features.
Synkowski DR; Reichlin M; Provost TT
J Rheumatol; 1982; 9(3):380-5. PubMed ID: 6981704
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced lupus: an update on its dermatologic aspects.
Marzano AV; Vezzoli P; Crosti C
Lupus; 2009 Oct; 18(11):935-40. PubMed ID: 19762393
[TBL] [Abstract][Full Text] [Related]
4. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset.
Sontheimer RD; Thomas JR; Gilliam JN
Arch Dermatol; 1979 Dec; 115(12):1409-15. PubMed ID: 533284
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of autoantibodies to a soluble cytoplasmic antigen in systemic lupus erythematosus and other connective tissue diseases.
Maddison P; Mogavero H; Provost TT; Reichlin M
J Rheumatol; 1979; 6(2):189-95. PubMed ID: 88520
[TBL] [Abstract][Full Text] [Related]
6. [The autoantibody profile and disease activity in patients with systemic lupus erythematosus].
Horák P; Hermanová Z; Faltýnek L; Pospísil Z; Scudla V
Vnitr Lek; 1997 Oct; 43(10):639-44. PubMed ID: 9601876
[TBL] [Abstract][Full Text] [Related]
7. Estradiol enhances binding to cultured human keratinocytes of antibodies specific for SS-A/Ro and SS-B/La. Another possible mechanism for estradiol influence of lupus erythematosus.
Furukawa F; Lyons MB; Lee LA; Coulter SN; Norris DA
J Immunol; 1988 Sep; 141(5):1480-8. PubMed ID: 2457617
[TBL] [Abstract][Full Text] [Related]
8. [Subacute cutaneous lupus erythematosus based on a study of 15 cases].
Marschalkó M; Dobozy E; Daróczy J; Gyimesi E; Horváth A
Orv Hetil; 1989 Dec; 130(49):2623-8. PubMed ID: 2689950
[TBL] [Abstract][Full Text] [Related]
9. Drug-induced lupus erythematosus.
Vedove CD; Del Giglio M; Schena D; Girolomoni G
Arch Dermatol Res; 2009 Jan; 301(1):99-105. PubMed ID: 18797892
[TBL] [Abstract][Full Text] [Related]
10. Systemic lupus erythematosus in the elderly: clinical and serological characteristics.
Catoggio LJ; Skinner RP; Smith G; Maddison PJ
J Rheumatol; 1984 Apr; 11(2):175-81. PubMed ID: 6610051
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to cytoplasmic antigens in lupus erythematosus. Serologic marker for systemic disease.
Provost TT; Razzaque A; Maddison PJ; Reichlin M
Arthritis Rheum; 1977; 20(8):1457-63. PubMed ID: 303519
[TBL] [Abstract][Full Text] [Related]
12. Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease.
Souza A; da Silva LM; Oliveira FR; Roselino AM; Louzada-Junior P
Lupus; 2009 Mar; 18(3):223-9. PubMed ID: 19213860
[TBL] [Abstract][Full Text] [Related]
13. Detection of Ro/SS-A antibodies in lupus erythematosus: what does it mean for the dermatologist?
Böckle BC; Stanarevic G; Sepp NT
J Am Acad Dermatol; 2013 Mar; 68(3):385-94. PubMed ID: 23069705
[TBL] [Abstract][Full Text] [Related]
14. [Anti-SSA/Ro and anti-SSB/La antibodies. What's new?].
Meyer O
Ann Med Interne (Paris); 2002 Dec; 153(8):520-9. PubMed ID: 12610426
[TBL] [Abstract][Full Text] [Related]
15. Is antibody clustering predictive of clinical subsets and damage in systemic lupus erythematosus?
To CH; Petri M
Arthritis Rheum; 2005 Dec; 52(12):4003-10. PubMed ID: 16320348
[TBL] [Abstract][Full Text] [Related]
16. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
[TBL] [Abstract][Full Text] [Related]
17. Facial telangiectasia: an unusual manifestation of neonatal lupus erythematosus.
Guinovart RM; Vicente A; Rovira C; Suñol M; González-Enseñat MA
Lupus; 2012 Apr; 21(5):552-5. PubMed ID: 22170760
[TBL] [Abstract][Full Text] [Related]
18. Anti-52 kDa Ro, anti-60 kDa Ro, and anti-La antibody profiles in neonatal lupus.
Gordon P; Khamashta MA; Rosenthal E; Simpson JM; Sharland G; Brucato A; Franceschini F; De Bosschere K; Meheus L; Meroni PL; Hughes GR; Buyon J
J Rheumatol; 2004 Dec; 31(12):2480-7. PubMed ID: 15570655
[TBL] [Abstract][Full Text] [Related]
19. [Subacute cutaneous lupus erythematosus: clinical aspects, immunology and therapy].
Ruzicka T; Bieber T; Meurer M
Wien Klin Wochenschr; 1987 Dec; 99(23):802-7. PubMed ID: 3324494
[TBL] [Abstract][Full Text] [Related]
20. The use of antibody to C5b-9 in the subclassification of lupus erythematosus.
Magro CM; Crowson AN; Harrist TJ
Br J Dermatol; 1996 May; 134(5):855-62. PubMed ID: 8736325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
